63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05338190 (ClinicalTrials.gov)	June 1, 2022	21/3/2022	Efficacy and Safety of Subcutaneous Belimumabor Placebo in Addition of Rituximab in Persistent or Ch ...	A Phase 3 Randomized and Double-blind Controlled Trial Comparing the Efficacy and Safety of Subcutan ...	Primary Immune Thrombocytopenia (ITP)	Drug: Combination of Rituximab with subcutaneous belimumab;Drug: Combination of Rituximabwith subcuta ...	Assistance Publique - Hôpitaux de Paris	GlaxoSmithKline	Not yet recruiting	18 Years	N/A	All	132	Phase 3	NULL
2	ChiCTR2200058433	2022-04-11	2022-04-09	Belimumabin combination with cyclosporine for corticosteroid-refractory primary immune thrombocytope ...	Efficacy and safety of belliumab in combination with cyclosporine in adults with persistent or chron ...	Primary immune thrombocytopenia	Group 1:belimumab and cyclosporine;	The Second Affiliated Hospital of Kunming Medical University	NULL	Pending			Both	Group 1:37;		China

First Previous1Next Last